Author Profile
Faheem Tahir
Author
Faheem holds a BSc (Hons) in Accounting and Finance from LUMS and has experience across financial analysis, valuation, project finance, and equity research. He currently works as a Financial Data Journalist at Insider Monkey, covering financial markets, companies, and investment-related developments. His background in financial analysis and research enables him to translate complex financial information into clear, data-driven insights for readers.
Contributing since: 2024
Articles by Faheem Tahir
Oracle (ORCL): Can Surging Cloud Revenue Outpace Its Financing Burden?
November 14 - News
Marvell Technology (MRVL): Can Its $20 Billion Revenue Outlook Justify the Valuation?
November 14 - News
NVIDIA (NVDA): Can AI Demand Sustain Growth Through Leadership Uncertainty?
November 14 - News
Core Scientific (CORZ): Can CoreWeave (CRWV) Revenue Growth Offset Expansion Risks?
November 14 - News
5 AI Infrastructure Stocks to Watch After CoreWeave’s Earnings
November 14 - News
10 AI Infrastructure Stocks to Watch After CoreWeave’s Earnings
November 13 - News
DuPont (DD): Semiconductor Water Demand Offers Growth Amid Middle East Delays
November 12 - Hedge Funds, News
Stantec (STN): Water Demand Drives Growth and Builds Project Backlog
November 12 - Hedge Funds, News
TETRA Technologies (TTI): Water Margins Expand as Desalination Projects Await Commercial Progress
November 12 - Hedge Funds, News
Tetra Tech (TTEK): Water Projects Support Growth as Cash Flow Strengthens
November 12 - Hedge Funds, News
Select Water Solutions (WTTR): Rising Water Volumes and Long-Term Contracts Support Infrastructure Expansion
November 12 - Hedge Funds, News
5 Best Water Recycling Stocks to Buy
November 12 - Hedge Funds, News
10 Best Water Recycling Stocks to Buy
November 11 - Hedge Funds, News
5 Best Gold Stocks to Buy According to Analysts
October 28 - Hedge Funds, News
10 Best Gold Stocks to Buy According to Analysts
Revolution Medicines (RVMD) Has an Approved Cancer Drug. Can Its $38 Billion Valuation Deliver?
October 20 - Hedge Funds, News
Tango Therapeutics (TNGX) Has Striking Pancreatic Cancer Data. How Much Is Priced In?
October 20 - Hedge Funds, News
Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?
October 20 - Hedge Funds, News
Merck (MRK) Has New Cancer Treatments. Can They Outgrow the Keytruda Patent Cliff?
October 20 - Hedge Funds, News
Cogent Biosciences (COGT) Nears Three FDA Decisions. What Is Its Pipeline Worth?
October 20 - Hedge Funds, News
Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?
October 20 - Hedge Funds, News
AstraZeneca (AZN) Adds Oncology Catalysts. Is the Pipeline Worth Its Earnings Multiple?
October 20 - Hedge Funds, News
Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?
October 20 - Hedge Funds, News
11 Best Cancer Stocks to Invest In Now
October 20 - Hedge Funds, News
Uber Technologies (UBER) Is Generating Cash, but Can Robotaxi Spending Preserve Its Valuation?
October 19 - Hedge Funds, News
eToro Group Ltd. (ETOR) Looks Cheap on Earnings. Can Trading Growth Outrun Costs?
October 19 - Hedge Funds, News
T-Mobile (TMUS) Faces a SpaceX Selloff. What Is Its Cash Flow Worth?
October 19 - Hedge Funds, News
Expedia Group, Inc. (EXPE) Trades Below Its Old Earnings Multiple. Is AI a Real Threat to Growth?
October 19 - Hedge Funds, News
Booking Holdings Inc. (BKNG) Is Building Its Own AI Agent. Can Cash Flow Defend the Multiple?
October 19 - Hedge Funds, News
Celsius Holdings, Inc. (CELH) Has Three Energy Brands. Can Earnings Catch Up With Its Valuation?
October 19 - Hedge Funds, News
First Solar (FSLR) Has a Huge Backlog. Will New Orders Deliver the Cash?
October 19 - Hedge Funds, News
Deckers Outdoor Corporation (DECK) Has Stronger Margins but a Lower Multiple. What Changed for Hoka?
October 19 - Hedge Funds, News
Micron (MU) Looks Cheap at 5 Times Forward Earnings. Can Its Profit Boom Last?
October 19 - Hedge Funds, News
AppLovin Corporation (APP) Grew Revenue 53%. What Must Happen to Defend Its Valuation?
October 19 - Hedge Funds, News
10 Best Undervalued Stocks to Buy Now According to Reddit
October 19 - Hedge Funds, News
BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble?
October 15 - Hedge Funds, News
QXO (QXO) Has an $18 Billion Revenue Base. Can Earnings Grow in a Housing Slump?
October 15 - Hedge Funds, News
On Holding (ONON) Targets Nearly $7 Billion in Sales. Can Premium Pricing Sustain Growth?
October 15 - Hedge Funds, News
Dutch Bros (BROS) Is Growing Sales 32%. Why Are Targets Falling?
October 15 - Hedge Funds, News
DraftKings (DKNG) Is Attracting More Bettors. Why Are Earnings Falling?
October 15 - Hedge Funds, News
Grab (GRAB) Reported $235 Million in Profit. Why Is Its Cash Flow Falling?
October 15 - Hedge Funds, News
Toast (TOST) Has Restaurant Scale. Can It Defend the Software Upsell?
October 15 - Hedge Funds, News
Liberty Energy (LBRT) Is Building an AI Power Business. Can It Outgrow Weak Oilfield Margins?
October 15 - Hedge Funds, News
BILL (BILL) Is Growing Earnings Faster Than Revenue. What Is Driving the Gap?
October 15 - Hedge Funds, News
Alamos Gold (AGI) Plans to Double Production. Can Gold’s Windfall Become Lasting Cash Flow?
October 15 - Hedge Funds, News
10 Best Growth Stocks Under $50 to Buy Now
October 15 - Hedge Funds, News
Marvell (MRVL) Raises Its 2028 Revenue Target to $20 Billion. Can Growth Justify the Premium?
October 13 - Hedge Funds, News
Jefferies Financial Group (JEF): Record Banking Revenue Is Not Enough to Resolve the Valuation Discount
October 12 - Hedge Funds, News
Delta Air Lines (DAL) Reports Record Revenue but Cuts Earnings Guidance. Can Profits Recover?
October 12 - Hedge Funds, News














































